Atoltivimab
Atoltivimab Basic information
- Product Name:
- Atoltivimab
- Synonyms:
-
- Atoltivimab
- Research Grade Atoltivimab (DVV03606)
- Research Grade Atoltivimab
- Atoltivimab (anti-EBOV)
- CAS:
- 2135632-29-8
- MW:
- 0
- Mol File:
- Mol File
More
Less
Atoltivimab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Atoltivimab Usage And Synthesis
Uses
Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection[1].
IC 50
EBOV
References
[1] Saxena D, et al. Atoltivimab/maftivimab/odesivimab (Inmazeb) combination to treat infection caused by Zaire ebolavirus. Drugs Today (Barc). 2021 Aug;57(8):483-490. DOI:10.1358/dot.2021.57.8.3280599
AtoltivimabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Guangzhou Hongyuan Chemical Co.,Ltd
- Tel
- 15817493340
- 981810490@qq.com
Wuhan Chemstan Biotechnology Co., Ltd.
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
Biolab Reagents
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com